Altimmune, Inc. (ALT)
Company Info
| ISIN | US02155H2004 |
|---|---|
| CUSIP | 02155H200 |
| Sector | Healthcare |
| Industry | Biotechnology |
Highlights
| Market Cap | $458.45M |
|---|---|
| EPS (TTM) | -$1.60 |
| PE Ratio | 33.50 |
| Total Revenue (TTM) | $404.00K |
| Gross Profit (TTM) | -$19.98M |
| EBITDA (TTM) | -$68.54M |
| Year Range | $2.09 - $14.84 |
| Target Price | $20.57 |
| Short % | 31.61% |
| Short Ratio | 4.83 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Popular comparisons: ALT vs. TQQQ, ALT vs. lly, ALT vs. VOO, ALT vs. XLK, ALT vs. BLNK, ALT vs. FDVV, ALT vs. METCB
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Altimmune, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Altimmune, Inc. had a return of -40.53% year-to-date (YTD) and 119.34% in the last 12 months. Over the past 10 years, Altimmune, Inc. had an annualized return of -33.59%, while the S&P 500 had an annualized return of 10.58%, indicating that Altimmune, Inc. did not perform as well as the benchmark.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | -40.53% | 13.20% |
| 1 month | -9.72% | -1.28% |
| 6 months | -27.91% | 10.32% |
| 1 year | 119.34% | 18.23% |
| 5 years (annualized) | 22.71% | 12.31% |
| 10 years (annualized) | -33.59% | 10.58% |
Monthly Returns
The table below presents the monthly returns of ALT, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -16.09% | 28.18% | -15.87% | -35.66% | 14.66% | -11.45% | -40.53% | ||||||
| 2023 | -17.08% | -7.70% | -66.48% | 19.67% | -20.00% | -12.62% | -6.23% | -23.56% | 2.77% | -7.31% | 31.12% | 256.01% | -31.61% |
| 2022 | -11.90% | -8.18% | -17.81% | -25.78% | 11.95% | 131.23% | 2.65% | 83.85% | -42.16% | -1.80% | -20.65% | 65.33% | 79.59% |
| 2021 | 26.60% | 11.62% | -11.36% | 2.41% | -12.58% | -22.13% | -7.92% | 65.27% | -24.55% | -4.51% | -2.87% | -12.68% | -18.79% |
| 2020 | -8.99% | 115.12% | -13.24% | -4.98% | 204.26% | 15.41% | 148.18% | -36.53% | -21.75% | -13.26% | 6.81% | -7.77% | 496.83% |
| 2019 | 54.85% | -15.67% | 7.81% | -1.38% | -15.03% | -2.06% | 0.84% | -12.08% | -7.58% | -2.05% | -4.71% | 3.85% | -8.25% |
| 2018 | -9.05% | -12.71% | -26.58% | -37.49% | -15.86% | -27.06% | -25.15% | -3.93% | -54.17% | -13.41% | -5.77% | -42.62% | -96.55% |
| 2017 | -4.62% | -70.88% | -9.83% | -10.44% | -41.52% | -24.71% | -21.25% | 0.00% | -7.94% | 3.45% | -24.58% | 9.94% | -93.86% |
| 2016 | -17.37% | 8.28% | 11.18% | 25.93% | -5.88% | 8.93% | 4.92% | 1.56% | 11.54% | -5.17% | 10.91% | 6.56% | 71.05% |
| 2015 | -8.84% | 1.82% | -2.98% | 1.23% | 3.64% | 5.26% | -6.11% | -14.20% | -8.28% | 26.32% | 4.76% | 7.95% | 4.97% |
| 2014 | 2.69% | -2.09% | -2.14% | -24.59% | 18.84% | -14.02% | -7.80% | 76.15% | -22.27% | -1.12% | -3.41% | 6.47% | -2.69% |
| 2013 | 27.68% | -9.09% | 30.77% | -7.06% | 12.66% | -10.67% | 11.32% | 20.90% | -1.87% | -2.38% | -8.78% | -0.53% | 66.07% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current risk-adjusted rank of ALT is 82, placing it in the top 18% of stocks on our website in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Altimmune, Inc. (ALT) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Altimmune, Inc. granted a 0.00% dividend yield in the last twelve months. The annual payout for that period amounted to $0.00 per share.
| Period | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|
| Dividend | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $2.91 |
Dividend yield | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 4.87% |
Monthly Dividends
The table displays the monthly dividend distributions for Altimmune, Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||
| 2023 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2022 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2021 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2020 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2019 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2018 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2017 | $2.91 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $2.91 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the Altimmune, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Altimmune, Inc. was 99.94%, occurring on Nov 19, 2019. The portfolio has not yet recovered.
The current Altimmune, Inc. drawdown is 99.75%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.94% | Mar 15, 2006 | 3409 | Nov 19, 2019 | — | — | — |
| -4.98% | Feb 28, 2006 | 5 | Mar 6, 2006 | 3 | Mar 9, 2006 | 8 |
| -2.7% | Oct 31, 2005 | 6 | Nov 7, 2005 | 32 | Dec 23, 2005 | 38 |
| -2.25% | Feb 7, 2006 | 7 | Feb 15, 2006 | 5 | Feb 23, 2006 | 12 |
| -2.25% | Jan 3, 2006 | 4 | Jan 6, 2006 | 16 | Jan 31, 2006 | 20 |
Volatility
Volatility Chart
The current Altimmune, Inc. volatility is 29.46%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
P/E Ratio
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Altimmune, Inc..
Loading data...
Income Statement
| TTM | |
|---|---|
| Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
| Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
| Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |